PharmaCyte Biotech Inc (PMCB)

[1234jklm]

There is one obvious beacon. Leonard Makowka was at the pre ind meeting with the FDA.?


There is another. We have had no positive news for too long now.

There is another. Some parties have been holding the pps down for a long time now.

There is another. The managers are rewarding themselves with extra share options.

The company has a facility to raise 50 million through ATM shares.

Chardin have been tasked with finding that investor.

Have they already found them.

That investor would be doing their due diligence and keeping the pps low. This has been happening for some time without dilution?

The best way of doing due diligence (and protect the value of your intended investment )would be to appoint your medical advisor as a manager of the company.

Our managers are seniors and will be thinking about cashing in and retirement. They don't have the energy to take this forward. They don't really have the energy to do a pivotal trial. But they have the reputation and the authority.

What they need is new energy and new funds.

Leonard Makowka is young enough to take this forward and he advises an investment group that wants to grow big consumer based companies. What would provide more consumers world wide and a higher value product than a cure for diabetes? A 5o million investment by ivest is not a big investment for them.

Why haven't we had much good news from the company for a while?

Maybe we've had the best news already and it's right in front of us.